experimental models such as carotid artery occlusion, ischemic brain injury, subarachnoid hemorrhage, and related conditions. Results: Current evidence suggests that hydrogen exerts neuroprotective effects by selectively scavenging reactive
Shiqin Ju1, 2, Qintao Xie1, 2, Yu Feng1, * · Translational Neurology and Neurosurgery · 1975
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This narrative review examined the available molecular-hydrogen literature. However, current evidence is limited by inconsistent administration protocols, unclear optimal dosage and timing, and a lack of large-scale clinical trials with long-term follow-up. hydrogen; cerebrovascular disease; neuroprotection; oxidative stress; anti-inflammatory; apoptosis Introduction Hydrogen was first discovered in the 17th century by Henry Cavendish. The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
What the Findings Mean
H2HUBB reviewed this publication as a synthesis of molecular-hydrogen research and summarizes the outcomes emphasized by the authors. However, current evidence is limited by inconsistent administration protocols, unclear optimal dosage and timing, and a lack of large-scale clinical trials with long-term follow-up. hydrogen; cerebrovascular disease; neuroprotection; oxidative stress; anti-inflammatory; apoptosis Introduction Hydrogen was first discovered in the 17th century by Henry Cavendish.
What the Researchers Studied
The authors reviewed experimental models such as carotid artery occlusion, ischemic brain injury, subarachnoid hemorrhage, and related conditions.
What Effects Did Molecular Hydrogen Have?
However, current evidence is limited by inconsistent administration protocols, unclear optimal dosage and timing, and a lack of large-scale clinical trials with long-term follow-up. hydrogen; cerebrovascular disease; neuroprotection; oxidative stress; anti-inflammatory; apoptosis Introduction Hydrogen was first discovered in the 17th century by Henry Cavendish. Experimental studies have demonstrated that hydrogen reduces oxidative stress, brain edema, neuronal apoptosis, infarct volume, and neurological deficits in various disease models.
Why These Findings Matter
The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
How Strong Is This Evidence?
This is review or synthesis evidence (narrative review).
Technical Study Details
H2HUBB classifies this publication as narrative review with review or synthesis evidence. The study used a narrative review. The hydrogen delivery method was multiple hydrogen delivery methods (hydrogen-rich water, gas inhalation, saline infusion).
Limitations and Safety
Reported limitations: However, current evidence is limited by inconsistent administration protocols, unclear optimal dosage and timing, and a lack of large-scale clinical trials with long-term follow-up. hydrogen; cerebrovascular disease; neuroprotection; oxidative stress; anti-inflammatory; apoptosis Introduction Hydrogen was first discovered in the 17th century by Henry Cavendish.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base. The original scholarly source is available at https://jf2.hep.com.cn/84f85e87d3d24acb893e909512e8eb24.pdf?response-content-disposition=attachment;%20filename=%22Hydrogen%20in%20Cerebrovascular%20Disease.pdf%22.